AIM 8-K 2026-09-14

AIM ImmunoTech Inc. (AIM) 8-K dated 2026-09-14 — accession 0001493152-26-042592.

AIM ImmunoTech Inc. (AIM) common stock.

AIM ImmunoTech Inc. filed a 8-K on 2026-09-14. Accession 0001493152-26-042592.

This 8-K covers: Material agreement (Item 1.01), Unregistered share sale (Item 3.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported AIM revenue for 2025-12-31 was $88.0K. Net income was -$14.0M. Revenue was down 48.2% from 2024-12-31 to 2025-12-31. AIM currently screens at market cap $4.6M.

Not investment advice. The AIM SEC hub lists recent forms. The stock page is the research view.